Applying Insurance Claims Data to Assess Quality of Care: A Compilation of Potential Indicators

1990 ◽  
Vol 16 (12) ◽  
pp. 424-438 ◽  
Author(s):  
Jonathan P. Weiner ◽  
Neil R. Powe ◽  
Donald M. Steinwachs ◽  
Greg Dent
1990 ◽  
Vol 6 (2) ◽  
pp. 263-271 ◽  
Author(s):  
Kathleen N. Lohr

AbstractThis article discusses data that might be used for measuring quality of care, for health care administrative purposes, and for tracking the use of technologies. The advantages and limitations of administrative data banks for research purposes and some process-of-care and outcome analysis are noted. Three important obstacles to their use—reliability of diagnosis and service information, unique patient identifiers, and provider identifiers—are discussed briefly.


2021 ◽  
Vol Volume 13 ◽  
pp. 969-980
Author(s):  
Khulood Al Mazrouei ◽  
Asma Ibrahim Almannaei ◽  
Faiza Medeni Nur ◽  
Nagham Bachnak ◽  
Ashraf Alzaabi

2021 ◽  
Vol 21 (1) ◽  
Author(s):  
Michael Stucki ◽  
Janina Nemitz ◽  
Maria Trottmann ◽  
Simon Wieser

Abstract Background Decomposing health care spending by disease, type of care, age, and sex can lead to a better understanding of the drivers of health care spending. But the lack of diagnostic coding in outpatient care often precludes a decomposition by disease. Yet, health insurance claims data hold a variety of diagnostic clues that may be used to identify diseases. Methods In this study, we decompose total outpatient care spending in Switzerland by age, sex, service type, and 42 exhaustive and mutually exclusive diseases according to the Global Burden of Disease classification. Using data of a large health insurance provider, we identify diseases based on diagnostic clues. These clues include type of medication, inpatient treatment, physician specialization, and disease specific outpatient treatments and examinations. We determine disease-specific spending by direct (clues-based) and indirect (regression-based) spending assignment. Results Our results suggest a high precision of disease identification for many diseases. Overall, 81% of outpatient spending can be assigned to diseases, mostly based on indirect assignment using regression. Outpatient spending is highest for musculoskeletal disorders (19.2%), followed by mental and substance use disorders (12.0%), sense organ diseases (8.7%) and cardiovascular diseases (8.6%). Neoplasms account for 7.3% of outpatient spending. Conclusions Our study shows the potential of health insurance claims data in identifying diseases when no diagnostic coding is available. These disease-specific spending estimates may inform Swiss health policies in cost containment and priority setting.


Sign in / Sign up

Export Citation Format

Share Document